Wedbush Securities’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.76M | Buy |
9,353
+764
| +9% | +$227K | 0.08% | 200 |
|
|
2025
Q4 | $2.35M | Buy |
8,589
+487
| +6% | +$132K | 0.07% | 223 |
|
|
2025
Q3 | $2.19M | Buy |
8,102
+1,402
| +21% | +$381K | 0.07% | 214 |
|
|
2025
Q2 | $1.85M | Buy |
6,700
+241
| +4% | +$65.5K | 0.06% | 239 |
|
|
2025
Q1 | $1.71M | Sell |
6,459
-502
| -7% | -$124K | 0.06% | 236 |
|
|
2024
Q4 | $1.62M | Buy |
6,961
+694
| +11% | +$160K | 0.06% | 240 |
|
|
2024
Q3 | $1.38M | Sell |
6,267
-390
| -6% | -$80.7K | 0.05% | 281 |
|
|
2024
Q2 | $1.31M | Hold |
6,657
| – | – | 0.05% | 301 |
|
|
2024
Q1 | $1.43M | Buy |
6,657
+1,073
| +19% | +$225K | 0.05% | 280 |
|
|
2023
Q4 | $1.18M | Buy |
5,584
+1,000
| +22% | +$213K | 0.05% | 293 |
|
|
2023
Q3 | $918K | Buy |
4,584
+449
| +11% | +$89.3K | 0.05% | 331 |
|
|
2023
Q2 | $766K | Sell |
4,135
-450
| -10% | -$83.2K | 0.04% | 392 |
|
|
2023
Q1 | $878K | Buy |
4,585
+99
| +2% | +$17.9K | 0.04% | 355 |
|
|
2022
Q4 | $754K | Sell |
4,486
-332
| -7% | -$57.7K | 0.04% | 381 |
|
|
2022
Q3 | $853K | Sell |
4,818
-318
| -6% | -$62.8K | 0.05% | 328 |
|
|
2022
Q2 | $1.05M | Sell |
5,136
-1,224
| -19% | -$259K | 0.06% | 279 |
|
|
2022
Q1 | $1.51M | Sell |
6,360
-78
| -1% | -$18.3K | 0.07% | 238 |
|
|
2021
Q4 | $1.47M | Buy |
6,438
+1,037
| +19% | +$228K | 0.06% | 258 |
|
|
2021
Q3 | $1.04M | Buy |
5,401
+316
| +6% | +$64K | 0.05% | 341 |
|
|
2021
Q2 | $1.08M | Buy |
5,085
+273
| +6% | +$57.6K | 0.05% | 339 |
|
|
2021
Q1 | $983K | Buy |
4,812
+449
| +10% | +$88.4K | 0.05% | 336 |
|
|
2020
Q4 | $794K | Buy |
4,363
+219
| +5% | +$37.2K | 0.07% | 299 |
|
|
2020
Q3 | $693K | Sell |
4,144
-1,612
| -28% | -$272K | 0.07% | 316 |
|
|
2020
Q2 | $936K | Buy |
5,756
+10
| +0.2% | +$1.79K | 0.09% | 229 |
|
|
2020
Q1 | $994K | Buy |
5,746
+482
| +9% | +$95.9K | 0.12% | 180 |
|
|
2019
Q4 | $1.06M | Sell |
5,264
-10
| -0.2% | -$2.05K | 0.09% | 229 |
|
|
2019
Q3 | $1.11M | Sell |
5,274
-877
| -14% | -$183K | 0.11% | 214 |
|
|
2019
Q2 | $1.19M | Buy |
6,151
+642
| +12% | +$118K | 0.12% | 200 |
|
|
2019
Q1 | $907K | Sell |
5,509
-613
| -10% | -$108K | 0.1% | 242 |
|
|
2018
Q4 | $1.15M | Buy |
6,122
+172
| +3% | +$31.8K | 0.15% | 169 |
|
|
2018
Q3 | $1.01M | Sell |
5,950
-200
| -3% | -$33.7K | 0.11% | 205 |
|
|
2018
Q2 | $1.01M | Buy |
6,150
+591
| +11% | +$96.5K | 0.13% | 193 |
|
|
2018
Q1 | $899K | Buy |
5,559
+457
| +9% | +$72.7K | 0.12% | 211 |
|
|
2017
Q4 | $745K | Buy |
5,102
+587
| +13% | +$83.6K | 0.09% | 265 |
|
|
2017
Q3 | $613K | Buy |
4,515
+185
| +4% | +$23.4K | 0.08% | 303 |
|
|
2017
Q2 | $542K | Buy |
4,330
+798
| +23% | +$95.4K | 0.07% | 360 |
|
|
2017
Q1 | $420K | Sell |
3,532
-422
| -11% | -$50.8K | 0.06% | 409 |
|
|
2016
Q4 | $456K | Sell |
3,954
-16
| -0.4% | -$1.78K | 0.07% | 362 |
|
|
2016
Q3 | $415K | Buy |
3,970
+969
| +32% | +$101K | 0.06% | 380 |
|
|
2016
Q2 | $292K | Sell |
3,001
-17
| -0.6% | -$1.61K | 0.05% | 470 |
|
|
2016
Q1 | $290K | Sell |
3,018
-198
| -6% | -$18K | 0.05% | 439 |
|
|
2015
Q4 | $291K | Buy |
3,216
+395
| +14% | +$37.2K | 0.05% | 416 |
|
|
2015
Q3 | $262K | Sell |
2,821
-227
| -7% | -$21.6K | 0.05% | 421 |
|
|
2015
Q2 | $284K | Sell |
3,048
-1,565
| -34% | -$146K | 0.05% | 453 |
|
|
2015
Q1 | $437K | Buy |
4,613
+423
| +10% | +$39.2K | 0.07% | 309 |
|
|
2014
Q4 | $371K | Buy |
4,190
+181
| +5% | +$15.3K | 0.06% | 340 |
|
|
2014
Q3 | $321K | Buy |
4,009
+66
| +2% | +$4.97K | 0.05% | 374 |
|
|
2014
Q2 | $280K | Buy |
3,943
+690
| +21% | +$48.6K | 0.04% | 421 |
|
|
2014
Q1 | $241K | Buy |
+3,253
| New | +$245K | 0.04% | 442 |
|
|
2013
Q4 | – | Sell |
-2,780
| Closed | -$205K | – | 595 |
|
|
2013
Q3 | $205K | Hold |
2,780
| – | – | 0.05% | 428 |
|
|
2013
Q2 | $211K | Buy |
+2,780
| New | +$182K | 0.06% | 400 |
|
Other funds holding CME
VCM
VPM
Wedbush Securities's CME Position: Q1 2026 in Review
Wedbush Securities increased its CME Group (CME) stake by 8.9% in Q1 2026, buying an estimated $227K and bringing the position to 9,353 shares worth $2.76M. The position accounts for 0.08% of the portfolio, ranked #200.
Wedbush Securities first reported a position in CME in Q2 2013 and has held it in 51 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Wedbush Securities held 9,353 shares of CME Group worth $2.76M as of Q1 2026.
- Wedbush Securities bought 764 CME Group shares in Q1 2026, an estimated $227K.
- CME Group made up 0.08% of Wedbush Securities's portfolio in Q1 2026, its #200 holding.
- Wedbush Securities first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.